Innovating for health

Biohit´s innovations prevent illnesses and improve quality of life

Start here

Are you an investor, a professional or a consumer?


Read more


Read more


Read more

News & Events

Bowel cancer screening is resource-intensive – GastroPanel® serves as a tool for endoscopy resource allocation 

Read more

NCGP – Nordic Congress of General Practice 2024

Read more

Medlab Middle East, 5.-8. February 2024 Dubai, UAE

Read more

Biohit Healthcare

Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit’s mission is “Innovating for Health”. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki since 1999, Small cap/Healthcare.

Read our annual report